/Investor DB

Cross Creek Advisors — 2014 Investments

3 investments dated 2014 · listed companies and verified rows first · show all

Fluidigm Corp.standardbio.comin𝕏Feb 2014

Standard BioTools develops proteomic and multi-omic solutions that enable researchers to discover biological insights through mass cytometry and tissue imaging.

BiotechDeep TechHealthtechMedical DevicesSouth San Francisco, US

Patrick S. Jones(Director)William M. Smith(Executive Officer)Grace Yow(Executive Officer)Evan Jones(Director)Samuel D. Colella(Director)Robert C. Jones(Executive Officer)

Thermo Fisher Scientificthermofisher.comin𝕏Feb 2014Acquired

Thermo Fisher provides life science products and laboratory equipment, including antibodies, consumables, biobanking resources, and Cryo-EM imaging systems for research labs and scientists.

BiotechEnterprise SoftwareHardwareHealthtechWaltham, US

Anthony Uzzo(Executive Officer, Director)inJoshua Geballe(Executive Officer, Director)James Gregory(Executive Officer, Director)Marc N. Casper(Executive Officer, Director)inAndrew J. Thomson(Executive Officer)Peter M. Wilver(Executive Officer)

Co-investorsARCH Venture PartnersBayMed Venture PartnersEric F. ThiessenExcel Venture ManagementHeran PartnersHighsage Ventures+6 more

Veracode, Inc.veracode.comin𝕏Aug 2014acquired by CA Technologies

Veracode provides an application security platform for scanning, identifying, and remediating software flaws across the software development lifecycle and supply chain.

CybersecurityDeveloper ToolsEnterprise SoftwareBurlington, US

Christopher Wysopal(Director, Executive Officer)Edward Goldfinger(Executive Officer)Dean J. Breda(Executive Officer)inRobert Brennan(Executive Officer, Director)Chris Wysopal(Founder)Christien Rioux(Founder)

Co-investors.406 VenturesAccompliceAgman PartnersAtlassian VenturesAviso VenturesBright Pixel Capital+8 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.